Hello:
In addition to being a rectal cancer survivor, I am a health writer who frequently focuses on cancer. I've been asked to write a brief article about the use of Signatera and other circulating tumor DNA tests to monitor CRC patients for potential residual disease. My understanding is that these are still in clinical trials, but some medical oncologists who specialize in GI cancers are using them.
If you would be willing to share any experiences you've had with these tests, and what institution is managing your care, I would welcome your insights! (This topic has come up before on the board but only in passing.)
Thanks!
Kris